Every advancement in the battle against cancer gives millions of those afflicted with this terrible illness hope. Researchers from the UC Davis Comprehensive Cancer Center in Sacramento,
California, have now proposed a novel and promising approach to cancer therapy. In particular, they published the findings of their investigation in the journal Cell Death & Differentiation.
The results demonstrate that CD95 receptors, sometimes referred to as Fas or “death receptors,” transmit a signal that triggers cancer cells to “self-destruct.” Targeting this receptor has not been.
Effective in the past. Jogender Tushir-Singh, a senior author of the research and an associate professor at the Department of Medical Microbiology and Immunology,
Said in the release, “But now that we’ve identified this epitope (target), there could be a therapeutic path forward to target Fas in tumors.”
